Natural history of brucellosis in an endemic region in different time periods

Acta Clinica Croatica, Supplement

Volumn 48, Issue 1, 2009, Pages 41-46

  Bosilkovski, Mile ^a,b   Dimzova, Marija ^a   Grozdanovski, Krsto ^a  

^a University Department of Infectious Diseases and Febrile Conditions   (Macedonia)

^b NONE   (Macedonia)

Author keywords

Brucellosis diagnosis; Brucellosis education; Brucellosis epidemiology; Brucellosis prevention and control; Macedonia; Zoonoses epidemiology

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

ADULT; ARTICLE; BRUCELLOSIS; CLINICAL FEATURE; COMPARATIVE STUDY; COMPREHENSION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CONTROL; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FOOD INTAKE; HISTORY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; RETROSPECTIVE STUDY; TIME; UNIVERSITY; CLINICAL LABORATORY; ENDEMIC DISEASE; OSTEOARTHROPATHY; PATIENT;

ADULT; AGED; BRUCELLOSIS; ENDEMIC DISEASES; FEMALE; HUMANS; MACEDONIA (REPUBLIC); MALE;

EID: 67651049672     PISSN: 03539474     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. TRUJILLO IZ, ZAVALA AN, CACERES JG, MIRANDA CQ. Brucellosis. Infect Dis Clin North Am 1994;8:225-241
2. BOSILKOVSKI M, KRTEVA Lj, DIMZOVA M, KONDOVA I. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis 2007;11:342-347 (Pubitemid 46994762)
3. WISE RI. Brucellosis in the United States. Past, present, and future. JAMA 1980;244:2318-2322
4. DOGANAY M, AYGEN B. Human brucellosis: an overview. Int J Infect Dis 2003;7:173-182
5. KUNDA J, FITZPATRICK J, KAZWALA R, FRENCH NP, SHIRIMA G, MacMILLAN A, et al. Health-seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public Health 2007;3:315.
6. NEOUIMINE N. Human brucellosis in the eastern Mediterranean region. Proceedings of the MZCP Report on the Third Workshop on Human and Animal Brucellosis. Epidemiological Surveillance in the MZCP Countries; 1998 May 4-5; Damascus, Syrian Arab Republic. Athens, Greece: WHO Mediterranean Zoonoses Control Centre, 1998:6-7.
7. PAPPAS G, PAPADIMITROU PH, AKRITIDIS N, CHRISTOU L, TSIANOS EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91-99 (Pubitemid 43138907)
8. nd ed. Skopje: Nova kniga, 1992.
9. BOSILKOVSKI M, KRTEVA Lj, CAPAROSKA S, DIMZOVA M. Osteoarticular involvement in brucellosis: a study of 196 cases in the Republic of Macedonia. Croat Med J 2004;45:727-733 (Pubitemid 40052929)
10. BOSILKOVSKI M, KRTEVA Lj, CAPAROSKA S, DIMZOVA M. Hip arthritis in brucellosis: a study of 33 cases in the Republic of Macedonia (FYROM). Int J Clin Pract 2004;58:1023-1027 (Pubitemid 39642412)
11. PAPPAS G, BOSILKOVSKI M, AKRITIDIS N, MASTORA M, KRTEVA Lj, TSIANOS E. Brucellosis and the respiratory system. Clin Infect Dis 2003;37:e95-9.
12. TAYLOR JP, PERDUE JN. The changing epidemiology of human brucellosis in Texas, 1977-1986. Am J Epidemiol 1989;130:160-165
13. ROBSON JM, HARRISON MW, WOOD RN, TILSE MH, McKAY AB, BRODRIBB R. Brucellosis: re-emergence and changing epidemiology in Queensland. Med J Aust 1993;159:153-158 (Pubitemid 23235819)
14. CHOMEL BB, DEBESS EE, MANGIAMELE DM, REILLY KF, FARVER TB, SUN RK, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992 - a shift towards foodborne transmission. J Infect Dis 1994;170:1216-1223
15. FOSGATE GT, CARPENTER TE, CHOMEN LL, CASE JT, DeBESS EE, REILLY KF. Time-space clustering of human brucellosis, California, 1973-1992. Emerging Infect Dis 2002;8:672-678
16. KERR WR, McCAUGHEY WJ, COGHLAN JD, PAYNE DJ, QUAIFE RA, ROBERTSON L, et al. Techniques and interpretations in the serological diagnosis of brucellosis in man. J Med Microbiol 1968;1:181-193
17. nd ed. Geneva (Switzerland): WHO Monograph Series, 1975:1-163.
18. GOMEZ MC, ROSA C, GEIJO P, ESCRIBANO MA. Estudio comparativo del test Brucellacapt con el test de Coombs para Brucella. Enferm Infecc Microbiol Clin 1999;17:283-285 (Pubitemid 29352494)
19. SERRA J, VELASCO J, GODOY P, MENDOZA J. Puede substituir la prueba de Brucellacapt a la prueba de Coombs en el diagnostico de la brucellosis humana? Enferm Infecc Microbiol Clin 2001;19:202-205 (Pubitemid 33678480)
20. YOUNG EJ. An overview of human brucellosis. Clin Infect Dis 1995;21:283-290
21. MINAS M, MINAS A, GOURGULIANIS K, STOURNARA A. Epidemiological and clinical aspects of human brucellosis in central Greece. Jpn J Infect Dis 2007;60:362-366 (Pubitemid 350177141)
22. HASANJANI ROUSHAN MR, MOHREZ M, SMAILNEJAD GANGI SM, SOLEJMANI AMIRI MJ, HAJIAHMEDI M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, northern Iran. Epidemiol Infect 2004;132:1109-1114 (Pubitemid 39642392)
23. CASAO MA, NAVARRO E, SOLERA J. Evaluation of Brucellacapt for the diagnosis of human brucellosis. J Infect 2004;49:102-108 (Pubitemid 38967344)
24. SOLERA J, RODRIGUEZ-ZAPATA M, GEIJO P, LARGO J, PAULINO J, SAEZ L, et al. Gecmei group. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother 1995;39:2061-2067
25. NICOLETTI P. The control of brucellosis - a veterinary responsibility. Saudi Med J 1992;13:10-13
26. MEMISH Z. Brucellosis control in Saudi Arabia: prospects and challenges. J Chemother 2001;13(Suppl 1):11-17 (Pubitemid 32531110)
27. COSIVI O. Animal brucellosis surveillance and control in the Mediterranean and Middle East countries. Proceedings of the MZCP Report on the Third Workshop on Human and Animal Brucellosis. Epidemiological Surveillance in the MZCP Countries; 1998 May 4-5; Damascus, Syrian Arab Republic. Athens, Greece: WHO Mediterranean Zoonoses Control Centre, 1998: 4-6.